Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-12-01T01:34:38.889Z Has data issue: false hasContentIssue false
  • English
  • Français

The Detection and Characterization of Nanoparticulate Heavy Metals in Epithelial Tissues in Patients with Nephrogenic Fibrosing Dermopathy

Published online by Cambridge University Press:  01 February 2011

Reed Ayers ,
Whitney High ,
John Chandler  and
Jim Ranville
Reed Ayers
Affiliation:
[email protected], Colorado School of Mines, Metallurgical and Materials engineering, 1500 Illinois St., Golden, CO, 80401, United States, 303-384-2337, 303-273-3795
Whitney High
Affiliation:
[email protected], University of Colorado Health Sciences Center, Dermatology, P.O. Box 6510, Mail Stop F703, Aurora, CO, 80045-0510, United States
John Chandler
Affiliation:
[email protected], Colorado School of Mines, Metallurgical and Materials engineering, 1500 Illinois St., Golden, CO, 80401, United States
Jim Ranville
Affiliation:
[email protected], Colorado School of Mines, Chemistry and Geochemistry, 1500 Illinois St., Golden, CO, 80401, United States
Get access

Abstract

Certain diseases have been associated with the administration of heavy elements as contrast agents to patients undergoing medical imaging procedures. Recently, the presence of gadolinium (Gd) administered as a paramagnetic contrast agent for MRI contrast studies was associated with the incidence of Nephrogenic Fibrosing Dermopathy (NFD), also called Nephrogenic Systemic Fibrosis (NSF). To determine specific causation, Gd and other metallic nanoparticles in various tissues must be detected directly and characterized in-situ. This is done to develop specific mechanisms for the chemical modification of the metal elements as the result of a biologic response. Fixed biopsies embedded in paraffin were sectioned at 3-5 μm thick, deparaffinized by hand (xylene and 100% ethyl alcohol), placed on carbon planchettes, and allowed to air dry. Deparaffinized tissues were examined using a field emission SEM (FE-SEM) to directly detect and image the presence of Gd as well as other metals. Backscatter electron (BSE) imaging (20kV) was used to discern metal particles within tissues. Energy dispersive spectroscopy (EDS) (15kV) was used to verify the specific elements present. This allowed for the spatial characterization of the nanoparticles within the tissues but due to the physical limitations of SEM/EDS, quantification of the amount of metal was not possible. Mass concentration of the metal elements was determined using inductively coupled plasma mass spectrometry (ICP-MS) on digested tissues. Thick tissue sections, >30 μm, were used for ICP-MS to provide enough mass for detection. These sections were taken from the histology blocks adjacent to the thin sections used in the FE-SEM. Gadolinium was detected in skin, heart, lung and liver tissues. The highest concentrations were found in heart and skin; both had average tissue concentrations greater than 200μg/g (100-450μg/g range). In skin, gadolinium nano-particulates were readily seen near cell body locations in autopsy samples and within the cells in biopsy samples. The cells where gadolinium was most easily found were along blood vessels. In the cells the agglomerates appear granular with a size of less than 100 nm. They are diffused throughout the cell but as of this time not associated with any particular cell structure. Subsequent work using TEM will examine that aspect as well as the specific ultrastructure and chemistry of the nanoparticles. In this investigation, gadolinium was detected in the tissues of a number of patients with NSF. Although neither dispositive of a pathophysiologic mechanism, nor proof of causation, the detection and quantification of gadolinium within tissues of NSF patients is supportive of the epidemiologic association between exposure to gadolinium containing contrast material and development of the disease.

Keywords

biologicalnanoscalenuclear magnetic resonance (NMR)
Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 1063: Symposium OO – Solids at the Biological Interface , 2007 , 1063-OO10-06
Copyright
Copyright © Materials Research Society 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. KWY, Chan, WT., Wong Small molecular gadolinium(III) complexes as MRI contrast agents for diagnostic imaging, Coordination Chemistry Reviews 2007; 251, 2428–2451.Google Scholar
2. Vinciane, C, DG, Martine Hermann, Humblet, V, Jacques, V, Mesbahi, M, Sauvage, C, Desreux, JF. Designing new MRI contrast agents: a coordination chemistry challenge. Coordination Chemistry Reviews 1999; 185–186: 451–470.Google Scholar
3. SE, Cowper, HS, Robin, SM, Steinberg, LD, Su, Gupta, S, LeBoit, PE. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000; 356:1000–1.Google Scholar
4. Cowper, SE. Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 2003; 15:785–90.Google Scholar
5. Cowper, SE. Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy. Am J Kidney Dis 2005; 46:763–5.Google Scholar
6. Leboit, PE. What nephrogenic fibrosing dermopathy might be. Arch Dermatol 2003; 139:928–30.Google Scholar
7. Gadolinium, Grobner T. – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006; 21:1104–1108.Google Scholar
8. High, WA, Ayers, RA, Adams, JR, Chang, A, Fitzpatrick, JE. High, WA, Ayers, RA, Adams, JR, Chang, A, Fitzpatrick, JE. Granulomatous reaction to titanium alloy: an unusual reaction to ear piercing [oral abstract]. American Society of Dermatopathology, 42nd Annual Meeting, Seattle, WA, October 20-23, 2005.Google Scholar
9. High, WA, Ayers, RA, Adams, JR, Chang, A, Fitzpatrick, JE. Granulomatous reaction to titanium alloy: an unusual reaction to ear piercing. J Am Acad Dermatol 2006; 55:(in press).Google Scholar
10. Goodhew, Peter J., H., J., Beanland, Richard. Electron Microscopy and Analysis. Taylor and Francis, London, 2001.Google Scholar
11. White, GW, Gibby, WA, Tweedle, MF. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Invest Radiol 2006; 41:272–8.Google Scholar
12. Krause, U, Kroencke, T, Spielhaupter, E, Taupitz, M, Kenn, W, Hamm, B, Hahn, D. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection. J Magn Reson Imaging 2005; 21:449–54.Google Scholar
13. White, GW, Gibby, WA, Tweedle, MF. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. Ivest radiol 2006; 41:272–278.Google Scholar
14. Krause, , Kroenke, T, Spielhaupter, E, Taupitz, M, Kenn, W, Hamm, B, Hahn, D. Contrast enhanced magnetic resonance angiography of the lower extermiites: standard dose vs. high dose gadodiamide injections. J Magn Reson Imaging 2005; 21:449–454.Google Scholar
15. Vorobiov, M, Basok, A, Tovbin, D, Shnaider, A, Katchko, L, Rogachev, B. Iron-mobilizing properties of the gadolinium-DTPA complex: clinical and experimental observations. Nephrol Dial Transplant 2003; 18:884–7.Google Scholar
16. Zhang, HL, Ersoy, H, Prince, MR. Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements. J Magn Reson Imaging 2006; 23:383–7.Google Scholar
17. Kimura, J, Ishiguchi, T, Matsuda, J, Ohno, R, Nakamura, A, Kamei, S, Ohno, K, Kawamura, T, Murata, K. Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents. Radiat Med 2005; 23: 322–326 Google Scholar